Australian researchers have uncovered resistance mutations to Sotrovimab – a monoclonal antibody treatment developed to minimise the risk of severe COVID-19 in patients who have underlying health conditions. Research led by the University of Sydney Institute for Infectious Diseases has reported genetic changes in the virus that causes COVID-19, associated with the development of resistance […]